Effects of a specific cysteinyl leukotriene antagonist, pranlukast, on antigen-induced cysteinyl leukotriene-mediated rhinitis in guinea pigs

Japanese Journal of Pharmacology

Volumn 75, Issue 4, 1997, Pages 347-353

  Fujita, Manabu ^a   Yonetomi, Yasuo ^a   Takeda, Hiroshi ^a   Nakagawa, Naoki ^a   Kawabata, Kazuhito ^a   Ohno, Hiroyuki ^a  

^a ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Allergic; Leukotriene; Ovalbumin; Pranlukast; Rhinitis

Indexed keywords

AZELASTINE; INDOMETACIN; MEPYRAMINE; OVALBUMIN; PEPTIDOLEUKOTRIENE; PRANLUKAST; THROMBOXANE B2;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GUINEA PIG; MALE; NONHUMAN; NOSE AIRWAY RESISTANCE; NOSE MUCOSA; ORAL DRUG ADMINISTRATION; PERMEABILITY;

EID: 0031459815     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.75.347     Document Type: Article

References (23)

1. Dvoracek JE, Yunginger JW, Kerr EB, Hyatt RE and Gleich GJ: Induction of nasal late-phase reactions by insufflation of ragweed-pollen extract. J Allergy Clin Immunol 73, 363-368 (1984)
2. White MV and Kaliner MA: Mediators of allergic rhinitis. J Allergy Clin Immunol 90, 699-704 (1992)
3. 4 in allergic rhinitis. Ann Allergy 60, 537-540 (1988)
4. Stechschulte DJ: Leukotriene in asthma and allergic rhinitis. New Engl J Med 323, 1769-1770 (1990)
5. 1-antihistamines, terfenadine and astemizole, for hay fever. Throax 39, 668-672 (1984)
6. 4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 151, 1734-1739 (1995)
7. Flowers BK, Proud D, Kagey-Sobotka A, Lichtenstein LM and Naclerio RM: The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surgery 102, 219-224 (1990)
8. Fujimura M, Sakamoto S, Kamino Y and Matsuda T: Effects of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir Med 87, 133-138 (1993)
9. Kreutner W, Sherwood J and Rizzo C: The effect of leukotriene antagonist, lipoxygenase inhibitors and selected standards on leukotriene-mediated allergic bronchospasm in guinea pigs. Agents Actions 28, 173-184 (1989)
10. Nakagawa N, Obata T, Kobayashi T, Okada Y, Nambu F, Terawaki T and Aishita H: In vivo pharmacologic profile of ONO-1078: A potent, selective and orally active peptide leukotriene (LT) antagonist. Jpn J Pharmacol 60, 217-225 (1992)
11. Zechel HJ, Brock N, Lenke D and Achterrath-Tuckermann U: Pharmacological and toxicological properties of azelastine, a novel antiallergic agent. Arzneimittelforschung 31, 1184-1193 (1981)
12. Nakagawa N, Obata T, Kobayashi T, Okada Y, Nambu F, Terawaki T, Fruya T, Muryobayashi K, Sawada M and Aishita H: Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig model of asthma. Eur J Pharmacol 235, 211-219 (1993)
13. Anderson WH, Donnell M, Simko BA and Welton AF: An in vivo model for measuring antigen-induced SRS-A-mediated bronchoconstriction and plasma SRS-A levels in the guinea-pig. Br J Pharmacol 78, 67-74 (1983)
14. Riichie DM, Sierchio JN, Capetola RJ and Rosenthale ME: SRSA-mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo. Agents Actions 11, 396-401 (1981)
15. 4 in vivo and in vitro. Proc Natl Acad Sci USA 77, 4354-4358 (1980)
16. 4 on the microvasculature of guinea-pig skin. Prostaglandins 21, 315-321 (1981)
17. 4 on nasal mucosa blood flow, nasal airway resistance and nasal secretion in human. Clin Allergy 16, 289-297 (1986)
18. Pipkorn U, Proud D, Lichtenstein LM, Schleimer RP, Peters SP, Adkinson NF Jr, Kagey-Sobotka A, Norman PS and Naclerio RM: Effects of short-term systemic glucocorticoid on human nasal mediator release after antigen challenge. J Clin Invest 80, 957-961 (1987)
19. Kemp JP, Buckley CE, Gershwin ME, Buchman E, Cascio FL, Chretien JH, Foster TS, Gordon WE, Jakle C, Klemawesch SJ, Weiner DL, Wille LJ and Tsai TH: Multicenter double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann Allergy 54, 502-509 (1985)
20. Meltzer EO, Storms WW, Pierson WE, Cummins LH, Orgel HA, Perhach JL and Hemsworth GR: Efficacy of azelastine in perennial allergic rhinitis: clinical and rhinomonometric evaluation. J Allergy Clin Immunol 82, 447-455 (1988)
21. Knapp HR: Reduced allergic-induced nasal congestion and leukotriene synthesis with an orally 5-lipoxygenase inhibitor. New Engl J Med 323, 1745-1748 (1990)
22. 4) inhibition of single doses of A-64077 in normal male volunteers. Clin Pharmacol Ther 45, 187 (1989)
23. Chand N, Diamantis W and Sofia RD: Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents Actions 19, 164-168 (1986)